Gilbert E F
Department of Pathology, Center for Health Sciences, University of Wisconsin, Madison.
Am J Cardiovasc Pathol. 1987;1(2):189-213.
Many metabolic diseases result in pathological changes within the cardiovascular system, often with the most severe effects on the function of the heart and great vessels. Metabolic disorders affecting the heart include disorders of amino acid metabolism, storage diseases, neuromuscular diseases, diseases of metal and pigment metabolism, carnitine deficiency, and connective tissue disorders. Several inborn errors of metabolism may involve the myocardium due to the accumulation of abnormal metabolites in the myocardial cells. In addition, the heart valves and coronary vessels may be involved. If the predominant effect is in the myocardial cell, it will be manifested clinically as a cardiomyopathy. Some disorders, in particular oxalosis, may involve the conduction system as a result of the deposition of oxalate crystals and result in conduction disturbances such as in alkaptonuria, primary oxalosis, and homocystinuria. Myocardial involvement may result in cardiomyopathy of the three functional types: (1) congestive, as in Fabry's disease, (2) hypertrophic, as in glycogen storage disease, type II, or (3) restrictive, as in Gaucher's disease. In the storage disease severe valvular as well as myocardial involvement occur predominantly in the glycogen storage diseases, types II-IV, mucolipidoses, sphingolipidoses, and neuronal ceroid lipofuscinosis. There are a variety of neuromuscular disorders that may be associated with cardiomyopathy, including the muscular dystrophies, Friedreich's ataxia, and Kugelberg-Welander syndrome. The pathological features of these conditions are not specific, but result usually in a congestive form of cardiomyopathy. Patients with metal and pigment metabolic disorders include iron storage disease, either hemochromatosis or transfusional hemosiderosis, Menkes' kinky hair syndrome, and Dubin-Johnson syndrome. Either a restrictive or a congestive form of cardiomyopathy may occur. The systemic form of carnitine deficiency is an autosomal recessive disorder and may present as a cardiomyopathy with congestive heart failure and lipid accumulation in the myocardial cells. Connective tissue disorders are generalized diseases that may involve the heart and valvular tissue, but also the blood vessels. These include Marfan's syndrome, Ehlers-Danlos syndrome, osteogenesis imperfecta, and pseudo-xanthoma elasticum.
许多代谢性疾病会导致心血管系统出现病理变化,通常对心脏和大血管的功能影响最为严重。影响心脏的代谢紊乱包括氨基酸代谢紊乱、贮积病、神经肌肉疾病、金属和色素代谢疾病、肉碱缺乏症以及结缔组织紊乱。一些先天性代谢缺陷可能由于心肌细胞中异常代谢产物的积累而累及心肌。此外,心脏瓣膜和冠状动脉也可能受累。如果主要影响心肌细胞,临床上将表现为心肌病。一些疾病,特别是草酸osis,可能由于草酸盐晶体的沉积而累及传导系统,并导致传导障碍,如黑尿症、原发性草酸osis和同型胱氨酸尿症。心肌受累可能导致三种功能类型的心肌病:(1)充血性,如法布里病;(2)肥厚性,如II型糖原贮积病;或(3)限制性,如高雪病。在贮积病中,严重的瓣膜和心肌受累主要发生在II-IV型糖原贮积病、粘脂贮积病、鞘脂贮积病和神经元蜡样脂褐质沉积症中。有多种神经肌肉疾病可能与心肌病有关,包括肌肉营养不良症、弗里德赖希共济失调和库格尔贝格-韦兰德综合征。这些疾病的病理特征并不特异,但通常会导致充血性心肌病。患有金属和色素代谢紊乱的患者包括铁贮积病,即血色素沉着症或输血性含铁血黄素沉着症、门克斯卷发综合征和杜宾-约翰逊综合征。可能会出现限制性或充血性心肌病。全身性肉碱缺乏症是一种常染色体隐性疾病,可能表现为伴有充血性心力衰竭和心肌细胞脂质积累的心肌病。结缔组织紊乱是全身性疾病,可能累及心脏和瓣膜组织,也可能累及血管。这些疾病包括马凡综合征、埃勒斯-当洛综合征、成骨不全症和弹性假黄瘤。